These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24780591)
1. Molecular dynamics investigation of the active site dynamics of mycobacterial cyclopropane synthase during various stages of the cyclopropanation process. Choudhury C; Deva Priyakumar U; Sastry GN J Struct Biol; 2014 Jul; 187(1):38-48. PubMed ID: 24780591 [TBL] [Abstract][Full Text] [Related]
2. Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation. Annaraj P D; Kadirvel P; Subramanian A; Anishetty S J Mol Graph Model; 2019 Sep; 91():61-71. PubMed ID: 31181453 [TBL] [Abstract][Full Text] [Related]
3. Dynamics based pharmacophore models for screening potential inhibitors of mycobacterial cyclopropane synthase. Choudhury C; Priyakumar UD; Sastry GN J Chem Inf Model; 2015 Apr; 55(4):848-60. PubMed ID: 25751016 [TBL] [Abstract][Full Text] [Related]
5. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. Rao V; Gao F; Chen B; Jacobs WR; Glickman MS J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578 [TBL] [Abstract][Full Text] [Related]
6. Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates. Barkan D; Rao V; Sukenick GD; Glickman MS J Bacteriol; 2010 Jul; 192(14):3661-8. PubMed ID: 20472794 [TBL] [Abstract][Full Text] [Related]
7. Structural and mechanistic comparison of the Cyclopropane Mycolic Acid Synthases (CMAS) protein family of Mycobacterium tuberculosis. Defelipe LA; Osman F; Marti MA; Turjanski AG Biochem Biophys Res Commun; 2018 Mar; 498(2):288-295. PubMed ID: 28859976 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of mycolic acid cyclopropane synthase: a theoretical study. Liao RZ; Georgieva P; Yu JG; Himo F Biochemistry; 2011 Mar; 50(9):1505-13. PubMed ID: 21241051 [TBL] [Abstract][Full Text] [Related]
9. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2. George KM; Yuan Y; Sherman DR; Barry CE J Biol Chem; 1995 Nov; 270(45):27292-8. PubMed ID: 7592990 [TBL] [Abstract][Full Text] [Related]
10. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid. Glickman MS J Biol Chem; 2003 Mar; 278(10):7844-9. PubMed ID: 12502719 [TBL] [Abstract][Full Text] [Related]
11. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Yuan Y; Lee RE; Besra GS; Belisle JT; Barry CE Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6630-4. PubMed ID: 7604045 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block. Corrales RM; Molle V; Leiba J; Mourey L; de Chastellier C; Kremer L J Biol Chem; 2012 Jul; 287(31):26187-99. PubMed ID: 22621931 [TBL] [Abstract][Full Text] [Related]
13. Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Barkan D; Liu Z; Sacchettini JC; Glickman MS Chem Biol; 2009 May; 16(5):499-509. PubMed ID: 19477414 [TBL] [Abstract][Full Text] [Related]
15. Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. Boissier F; Bardou F; Guillet V; Uttenweiler-Joseph S; Daffé M; Quémard A; Mourey L J Biol Chem; 2006 Feb; 281(7):4434-45. PubMed ID: 16356931 [TBL] [Abstract][Full Text] [Related]
16. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors. da Silva Lima CH; de Alencastro RB; Kaiser CR; de Souza MV; Rodrigues CR; Albuquerque MG Int J Mol Sci; 2015 Oct; 16(10):23695-722. PubMed ID: 26457706 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Barkan D; Hedhli D; Yan HG; Huygen K; Glickman MS Infect Immun; 2012 Jun; 80(6):1958-68. PubMed ID: 22431648 [TBL] [Abstract][Full Text] [Related]
18. MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. Yuan Y; Crane DC; Musser JM; Sreevatsan S; Barry CE J Biol Chem; 1997 Apr; 272(15):10041-9. PubMed ID: 9092547 [TBL] [Abstract][Full Text] [Related]
19. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity. Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037 [TBL] [Abstract][Full Text] [Related]
20. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]